Effects of clomiphene citrate on seminal parameters in idiopathic oligospermia: a single blinded prospective randomized controlled trial
Keywords:Clomiphene citrate, Idiopathic oligospermia, Male factor infertility, Pregnancy rate, Semen analysis, Sperm count
Background: About 15% married couples face problem of infertility of which male factor is implicated in 20% of them. In about 30% infertile men no causative factor is found and the condition is termed “Idiopathic”. They are often treated by empirical medications or Assisted Reproductive Technologies (ART) although success in few; our present study is carried on effects of clomephene citrate on seminal parameters in idiopathic oligospermia.
Methods: This single blinded prospective randomized controlled trial was conducted at the infertility clinic with 200 idiopathic oligospermic men (sperm count <15 millions/ ml of ejaculate) after fulfilling inclusion and exclusion criteria and were alternately allocated into two equal groups - “Group C” receiving clomephene citrate tablets and “ Group P” receiving placebo after concealment. Semen analysis data were collected at baseline and every month and three months of completion of treatment and were summarized by routine descriptive statistical analysis.
Results: The demographic characteristics like mean age is comparative in both groups but duration of infertility of >2 years is more in group C than group p (4.3±3.06 versus 4.1±2.57). The semen volume, spermatozoa count, sperm motility and not normal form are all increased after three months of treatment in group C as are biochemical parameters like total testosterone and serum FSH, LH and as also pregnancy rate (22% versus 4%).
Conclusions: This study showed clomiphene citrate treatment protocol is inexpensive, relatively safe and easy to administer and improves semen volume, sperm count and sperm motility but not sperm morphology by increasing serum testosterone, FSH and LH in male and resulting in improved pregnancy rate in female partners.
Rubenstein JN, Brannigan RE. Infertility, Male. e Medicine. 2008:1-31. Available at: www. emedicine.com/med/TOPIC 1167. HTM.
Sigman M, Jarow JP. Male Infertility. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, eds. Campbell - Walsh Urology. Vol 1. Philadelphia: Saunders 2007: 609-53.
Jalbani MH, Rikhasor RM, Pathai S, Solangi GA, Baloch R. Causes of Azoospermia in infertile men. Original Paper. 2001;7(2):36-8.
Rikhasor RM, Pathai S, Jalbani MH, Pirzado ZA, Abbasi SA. Semen analysis of infertile men and plasma levels of LH, FSH and Testosterone in oligospermia. Original Paper. 2001;7(2):30-2.
World Health Organisation. 2010. Laboratory manual for the examination and processing of human semen. Available at: http//whqlibdoc.who.int/publications/2010/9789241547789 - eng.pdf.
Cavallini G. Male idiopathic oligoasthenoteratozoospermia. Asian J Androl. 2006;8(2):143-57.
Etiology of infertility study of 6009 infertile couples over 17 years. JOGI R Rajan. 1990;40(3):400-6.
Akin JW. The use of clomiphene citrate in the treatment of azoospermia secondary to incomplete androgen resistance. Fertil Steril. 1993;59(1):223-4.
Hussein A, Ozgok Y, Ross L, Neiderberger C. Clomiphene administration for cases of non-obstructive azoospermia: A multicenter study. Elsevier J Androl. 2005;26(6):787-91.
Pusch HH, Haas J, Purstner P. Results of low dose treatment of oligospermia with clomiphene citrate. Androl. 1986;18:561.
Skinner MK, Griwold MD. Sertoli cells synthesize and secrete transferrin-like protein. J Biol Chem 1980;255(20):9523-25.
Gonzales GF. Function of seminal vesicles and their role in male infertility. Asian J Androl. 2001;3(4):251-8.
Fuse H, Ohta S, Sakamoto M, Katayama T. Changes in seminal plasma transferrin concentration following administration of clomiphene citrate. Arch Androl. 1993;31(2):139-45.
Patankar SS, Kaore SB, Sawane MV, Mishra NV, Deshkari AM. Effects of clomiphene citrate on sperm density in male partners of infertile couples. Indian J Physiol Pharmacol. 2007;51(2):195-8.
Zaman S, Zulfikar S, Khan S. Evaluation of effects of clomiphene citrate on serum testosterone FSH levels and seminal parameters in idiopathic oligospermia. Biomedica. 2009;25:48-51.
Moradi M, Moradi A, Alemi M, Ahmadnia H. Safety and efficacy of clomiphene citrate and L- carnitine in idiopathic male infertility: a comparative study. Urol J. 2010;7:188-93.
Ronnberg L. The effect of clomiphene citrate on different sperm parameters and serum hormone levels in preselected infertile men: a controlled double blind cross-over study. Int J Androl. 1980;3:479-86.
Ghanem H, Shaeer O, El-Segini A. Combination of clomiphene citrate and antioxidant therapy for idiopathic male infertility: a randomized controlled trial. Fertil Steril. 2010;93:2232-5.
Gray AT, Jacobson J, Parez JB, Hodge MB, Velasquez E. Clomiphene increases free testosterone levels in men with both secondary hypogonadism and erectile dysfunction: who does and does not benefit? Int J Impot Res. 2003;15:156-65.
Da Ros CT, Averbeck MA. Twenty-five milligrams of clomiphene citrate presents positive effect on treatment of male testosterone deficiency - a prospective study. Int Braz J Urol. 2012;38:512-8.
Wang C, Chan C, Wong K, Yeung K. Comparison of the effectiveness of placebo, clomiphene citrate, mesterolone, pentoxyfylline and testosterone rebound therapy for the treatment of idiopathic oligospermia. Fertil Steril. 1983;4:358-65.
Siddiq FM, Sigman M. A new look at the management of infertility. Urol Clin North Am. 2002;29(4):949-63.